Rivercell, a Paris-based biotech and AI company building proprietary data infrastructure on how human cells respond to treatments and training a global cell model to predict those responses, has raised a $25.0M Seed round led by HV. The announcement represents its Seed financing milestone. The excerpt provided did not disclose metrics such as clients, revenue, pipeline, or employee count, nor did it detail specific use of proceeds or expansion plans beyond its core platform, and no additional investors were named.